Tag: biologics

Why Some Brand-Name Drugs Have No Generic Alternatives: Patents, Biologics, and Market Tactics

Why Some Brand-Name Drugs Have No Generic Alternatives: Patents, Biologics, and Market Tactics

Discover why some brand-name drugs lack generic alternatives. From patent thickets and biologic complexities to pay-for-delay tactics, understand the real reasons behind high drug prices and what patients can do.

Read More
Lot-to-Lot Variability in Biologics and Biosimilars: What You Need to Know

Lot-to-Lot Variability in Biologics and Biosimilars: What You Need to Know

Lot-to-lot variability is a natural part of biologic and biosimilar manufacturing. Unlike generics, these drugs aren't identical from batch to batch - but they're still safe and effective. Here's how regulators, labs, and manufacturers manage it.

Read More